681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Twist Bioscience Files Prospectus Supplement for Share Resale
Reg. FD
Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock
Reports Fiscal Third Quarter 2026 Financial Results
Reports Fiscal Second Quarter 2026 Financial Results
Twist Bioscience Issues 632,328 Shares in Stock Purchase Agreements
Election of Directors at Twist Bioscience Annual Meeting
Reports Fiscal First Quarter 2026 Financial Results
Q3
Q2
Amended Quarterly Report
Q1
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership
Prospectus filed pursuant to Rule 424(b)(7)
Submission Upload
Correspondence